Product Information
ARIPIPRAZOLE 30 MG TABLET is a generic product labeled by Ascend Laboratories, LLC, priced at $0.1735 per EA under NDC 67877043505. Its NADAC has been published 318 times since Sep 2, 2020.
FDA first approved this application on Feb 21, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
30 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877043505
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ARIPIPRAZOLEApproval Type
Generic (ANDA)
FDA Application
ANDA207105FDA Approved
2/21/2019
TE Code
AB
On Market Since
2/27/2019
Pharmacological Classes
Price Statistics
The NADAC for ARIPIPRAZOLE 30 MG TABLET has been published 318 times since Sep 2, 2020, and over the history we have for it it has declined 43.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1735 per EA |
|---|---|
| All-time high | $0.3312 (Jan 13, 2021) |
| All-time low | $0.1365 (Nov 20, 2024) |
| 52-week high | $0.1764 |
| 52-week low | $0.1567 |
| Median price | $0.2371 |
| Average price | $0.2320 |
| Largest weekly change | +41.4% (Aug 21, 2024) |
| Weeks tracked | 318 |
| Tracking since | Sep 2, 2020 |
Generic Alternatives
The matcher finds 14 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Ascend Laboratories, LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Aripiprazole market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Atypical Antipsychotic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ARIPIPRAZOLE 30 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for ARIPIPRAZOLE 30 MG TABLET, manufactured by Ascend Laboratories, LLC, is $0.1735 per EA (NDC 67877043505), effective Sep 30, 2026.
How has the price of ARIPIPRAZOLE 30 MG TABLET changed over time?
Over the history we have for it, the NADAC for ARIPIPRAZOLE 30 MG TABLET has declined 43.3%. It has been tracked across 318 weekly CMS publications since Sep 2, 2020.
What are the highest and lowest recorded NADAC prices for ARIPIPRAZOLE 30 MG TABLET?
Since Sep 2, 2020, the NADAC for ARIPIPRAZOLE 30 MG TABLET has ranged from a low of $0.1365 (Nov 20, 2024) to a high of $0.3312 (Jan 13, 2021), with a median of $0.2371 per EA.
Are there cheaper alternatives to ARIPIPRAZOLE 30 MG TABLET?
14 manufacturers publish a NADAC-priced product with the same active ingredient and strength as ARIPIPRAZOLE 30 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures ARIPIPRAZOLE 30 MG TABLET?
ARIPIPRAZOLE 30 MG TABLET (NDC 67877043505) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.